Icodec insulin - revolution in diabetes type 2 insulin therapy

Introduction: Basal glucose control in diabetes type 2 is commonly maintained by a single, once-daily administration of insulin through subcutaneous injection. Insulin icodec, a novel ultralong-acting lipidated analog validates the concept of a once-weekly basal injection that is less burdensome, y...

Full description

Bibliographic Details
Main Authors: Michał Dobrzyński, Jakub Czarnota, Tomasz Skubel, Małgorzata Drozd, Iga Dudek, Natalia Rybak
Format: Article
Language:English
Published: Kazimierz Wielki University 2022-08-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:https://apcz.umk.pl/JEHS/article/view/39466